ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 300 filers reported holding ACADIA PHARMACEUTICALS INC in Q2 2020. The put-call ratio across all filers is 1.07 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $2,886,000 | -93.3% | 59,931 | -94.1% | 0.02% | -94.0% |
| Q1 2020 | $42,988,000 | -0.1% | 1,017,487 | +1.2% | 0.27% | +29.0% |
| Q4 2019 | $43,011,000 | +18.2% | 1,005,406 | -0.5% | 0.21% | +10.1% |
| Q3 2019 | $36,373,000 | +36.1% | 1,010,663 | +1.1% | 0.19% | +37.2% |
| Q2 2019 | $26,733,000 | -14.2% | 1,000,118 | +2.1% | 0.14% | -35.1% |
| Q3 2016 | $31,151,000 | +0.5% | 979,303 | +2.5% | 0.21% | -1.9% |
| Q2 2016 | $31,000,000 | +7.5% | 955,027 | -7.4% | 0.22% | +7.5% |
| Q1 2016 | $28,837,000 | +22.3% | 1,031,373 | +55.9% | 0.20% | +26.6% |
| Q4 2015 | $23,583,000 | -42.1% | 661,516 | -46.3% | 0.16% | +13.7% |
| Q3 2015 | $40,764,000 | – | 1,232,708 | – | 0.14% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Finepoint Capital LP | 556,553 | $11,598,565 | 5.78% |
| Baker Brothers Advisors | 42,864,612 | $893,298,514 | 5.15% |
| RTW INVESTMENTS, LP | 11,576,537 | $241,255,031 | 5.09% |
| Palo Alto Investors LP | 2,405,793 | $50,136,726 | 4.74% |
| Birchview Capital, LP | 240,400 | $5,009,936 | 4.26% |
| EcoR1 Capital, LLC | 5,991,479 | $124,862,422 | 4.21% |
| EMERALD ADVISERS, LLC | 1,681,052 | $35,033,124 | 1.70% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 1,303,988 | $27,175,110 | 1.64% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 179,702 | $3,739,599 | 1.26% |
| SECTOR GAMMA AS | 179,785 | $3,746,719 | 0.96% |